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I-region-associated (Ia) antigens are more readily detected on mouse dendritic cells 
(1)(2) 1 and B  lymphocytes than on peritoneal and spleen macrophages (Mth) from the 
same animals (1). In contrast, expression of Mth Ia increases in mice infected with live 
mycobacteria (Bacille Calmette-Gu~rin) (2, 3). We therefore asked if Mq~ Ia could be 
influenced by lymphokine (LK) released by T  cells mediating anti-microbial immu- 
nity. We have chosen to study the effects of LK from T~ypanosoma  cntzi-immune mouse 
spleen cells. This source of LK  is a  potent  activator of M~  microbicidal, secretory, 
and tumoricidal capacities (4-6). The effects of LK on the Mth surface were monitored 
using  radioiodinated monoclonal  antibodies directed  to  Ia  and  four  other  plasma 
membrane  antigens.  We  report  that  addition  of immune  LK  selectively enhances 
expression and synthesis of Mth Ia. Populations that <5% Ia positive can be converted 
to >95% positive. However, these homogeneous populations of Ia-bearing Mth do not 
stimulate the primary mixed leukocyte reaction (1 °  MLR). 
Materials and  Methods 
Mice.  Male and female B6D2F1,  C57BL/6, and DBA/2 (Trudeau Institute, Saranac Lake, 
N. Y.) and CBA/J (The Jackson Laboratory, Bar Harbor, Maine) mice were used, generally at 
6-8 wk of age. 
Cells.  Peritoneal Mth were obtained from mice primed 4 d  previously with  1 ml proteose 
peptone intraperitoneally. 2 h after explantation, nonadherent cells were removed by washing, 
and the adherent monolayer maintained in Dulbecco's medium supplemented with 10% heat- 
inactivated fetal calf serum  (D10;  both  reagents from  Grand  Island Biological Co.,  Grand 
Island, N. Y.) and antibiotics. The adherent cells were >95% M~ because they were phagocytic 
for opsonized erythrocytes and expressed the Mac-l surface antigen (7), which is abundant on 
mouse Mq~ but weak or absent on mouse B cells and DC.  (Nussenzweig et al. Manuscript in 
preparation.) Adherent cells were maintained on  13-mm diameter glass cover slips (Gold Seal, 
No.  3550).  DC were obtained from mouse spleen as previously described (l, 3).  Proteins on 
coverslips that bore Mt  h were measured with a Lowry assay using lysozyme as standard. 
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LK.  Spleen cells  were  dissociated from groups of three  to  four CBA/~  mice that  were 
unprimed or were infected with T. cn~zi 2-3 wk earlier as described (5, 6).  10  spleen cells were 
cultured for  48  h  in 6.5  ml  Dulbecco's medium supplemented with  2%  fetal  calf serum, 
antibiotics, and 5 ×  10  -5 2-mercaptoethanol in 100-mm tissue culture dishes (Falcon Labware, 
Div. of Becton, Dickinson & Co., Oxnard, Calif.). Immune LK refers to medium from T. cruzi- 
immune cells boosted with 6  ×  106 heat-killed T. cru,zi (HKT) in vitro; control LK usually 
refers  to  nonimmune cells  boosted with  HKT.  CBA  Oa  k)  mice were used  to  generate LK 
because this strain does  not react with the anti-Ia  b'a reagent used in these experiments (see 
below). Therefore LK-induced changes on Ia  b'd cells are Mq~ rather than LK derived. LK was 
added to peritoneal Mt  h at  a  final concentration of 1-30%  vol:vol and changed daily. Six 
different preparations of immune, and four preparations of control LK, were tested with similar 
effects.  To  determine  if LK  production  required  T  cells,  we  treated  spleen  cells  with  a 
monoclonal  rat anti-mouse  Thy- 1 (our clone B5-3) and complement (Rabbit LOTOX; Accurate 
Chemical & Scientific Corp., Hicksville, N. Y.) before culture with specific antigen. 
Monodonal Antibodies.  Five monoclonal rat anti-mouse reagents were used, all produced by 
hybridizing immune rat spleen with the mouse myeloma P3U-1, kindly supplied by Dr. M. 
Scharff, Albert Einstein College of Medicine, Bronx, N. Y. Clones were picked on soft agar, and 
antibody-rich ascites formed during growth in irradiated mice. Ig rich in monoclonal antibody 
was purified by passage over DEAE-cellulose. Three non-MHC reagents were derived by Dr. 
J. Unkeless, The Rockefeller University, New York, with rat spleen cells immune to the mouse 
M~ cell line J774. The three clones that react with all spleen and peritoneal Mth were:  1.21 J 
a clone that reacts with mouse M~ and granulocytes but not with most lymphocytes and DC 
and  appears  to  be  similar by  immunoprecipitation analysis to  clone Mac-1  described  by 
Springer et al. (7) (8); 2.6, another clone that recognizes a 21,000-mol wt polypeptide found on 
mouse M~ (8); and 24G2 a clone that recognizes the IgG2b, or trypsin-resistant, Fc receptor (9). 
An Fab fragment of clone 24G2 antibody, produced by papain cleavage, was used (9). The 
anti-major histocompatibility  complex (MHC) reagents were produced in rats immunized with 
live BALB/c (H-2d) DC intravenously. Binding studies with iodinated monoclonal antibodies 
were performed on spleen cells of appropriate MHC congenic and recombinant strains. Clone 
lad  d  B21-2 seems to be an anti I-A ' , and clone B25-1 an anti H-2D  reagent (Table I). Clone B21- 
2 immunoprecipitates typical class II polypeptides (10) and competes in sequential immuno- 
precipitation protocols with anti-Ia 8  (anti-I-Ab'd), but not anti-Ia 7 (anti-LEa'k),  alloantisera 
obtained from the Research Resources Branch, National Institutes of Health, Bethesda, Md. 
Clone B25-1 precipitates typical class I (45 and 13 mol wt) polypeptides (10). 
Binding125ofMonoclonal  Antibodies.  Each of the monoclonal reagents was lodmated'  '  with carrier- 
free Na[  I] (New England Nuclear, Boston, Mass.; or Amersham/Searle, Arlington Heights, 
Ill.) to a level of 1-2 ~Ci//~g and stored as 20-50/~g/ml solutions in phosphate-buffered saline 
to which sodium azide (0.02%) and 1 mg/ml bovine serum albumin were added. Chloramine 
T  or iodogen  (Pierce Chemical Co.,  Rockford,  Ill.)  was  used  for  iodination. Quantitative 
binding  studies were performed on ice using cells adherent to 13-mm glass cover slips. Duplicate 
cover slips  were exposed to 0.2  ml antibody at  0.2-1.0 #g/ml culture medium with  0.02% 
sodium azide. 1/~g/ml is at or close to the level required to saturate most binding sites for all 
antibodies. Equilibrium was reached within 30-60 min, after which the cover slips were rinsed 
through three successive changes of medium and fixed in 1.25% glutaraldehyde. The cover slips 
were  counted (Autogamma 5220;  Packard  Instrument Co.,  Inc., Downers Grove, Ill.)  and, 
when  necessary,  processed  further  for  light  microscope  radioautography  as  described  (3). 
Controls  for  the  specificity of binding in  both  quantitative and  radioautographic  assays 
included: (a) binding of the monoclonal was inhibited close to the background level by a 20- 
fold excess of unlabeled specific antibody; (b) binding was not inhibited if saturating levels of 
the anti-Fc receptor reagent, clone 24G2, were included during the binding assay;  and (c)  in 
the case of anti-MHC reagents, binding above the no cell background was not seen with Mq~ 
from the inappropriate haplotype, e.g., CBA. In all cases, background binding on cover slips 
without cells was <5-10% of specific binding. We suspect that the monoclonal antibodies have 
access to the M~ surfaces  facing the culture medium and the culture vessel, because Dr. J. 
Michl, The Rockefeller University, (Personal communication.) has demonstrated that concan- 
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TAnLE  I 
Binding of Monoclonal Anti-MHC Antibodies to Mouse Spleen 
Major histocompatibility com-  Antibody bound by 2.5 ×  10  s 
Mouse  plex  spleen cells 
strain  Clone 
I-  1.0  0.5  0.25  0. ] 25 
K  A  I-B  I-J  I-E  I-C:  D  #g/ml  ,ttg/ml  pg/ml  /~g/ml 
cp?n 
No cells  --  562  302  189  125 
B10.BR  k  k  k  k  k  k  k  415  196  116  110 
B 10.A  k  k  k  k  k  d  d  338  202  132  98 
B10.D2  d  d  d  d  d  d  d  17,615  11,345  6,095  3,032 
C57BL/6  b  b  b  b  b  b  b  B21-2 (anti-I-A  b'd)  10,440  7,167  4,538  2,828 
B 10.A(5R)  b  b  b  k  k  d  d  11,404  7,397  4,056  2,450 
B 10.A(4R)  k  k  b  b  b  b  b  500  221  151  102 
C:3H  k  k  k  k  k  k  k  408  210  154  90 
C:3H.OH  d  d  d  d  d  d  k  26,542  12,359  7,084  3,662 
No cells  --  122  106  52 
B 10.BR  k  k  k  k  k  k  k  I00  74  79 
B10.A  k  k  k  k  k  d  d  1,234  1,059  505 
B 10.D2  d  d  d  d  d  d  d  1,045  939  495 
C57BL/6  b  b  b  b  b  b  b  B25-1 (anti-H-2D  a)  153  102  95 
B 1O.A(SR)  b  b  b  k  k  d  d  1,294  858  523 
B 10.A(4R)  k  k  b  b  b  b  b  107  84  66 
C:3H  k  k  k  k  k  k  k  94  92  65 
C:3H.OH  d  d  d  d  d  d  k  90  84  66 
2.5 ×  105 spleen cells  from several mouse strains were spun onto 96-well  microtest dishes (Costar, Data 
Packaging, Cambridge, Mass.) coated with poly-L-lysine (40 #g/ml). The dishes were rinsed in cold medium 
containing 5% serum and then 0.2 ml of 12aI-monoclonal antibody was added in various doses. Both clone 
B21-2  and B25-1  had a  4.5  ×  106 cpm/#g sp act. Equilibrium was reached within  1 h. The cells  were 
washed  in  medium  and  lysed  in  0.1  N  NaOH  before  counting.  Data  are  the  means  of  triplicate 
determinations with SD of 5-20%.  Strains bearing Ia-reactive cells  in binding studies were 50-70% Ia- 
positive by cytotoxicity assays.  Binding studies of this sort were performed at least three times on each 
strain with similar results.  C:57BL/10 mice (not shown here) behaved similarly to C:57BL/6.  Mice were 
provided by Dr. Perrin White, The Rockefeller University. The polypeptides precipitated by clones B25-1 
and B21-2 from radiolabeled spleen cells are typical class I and II MHC: polypeptides, respectively (10). 
Biosynthesis of Plasma Membrane Antigens.  Adherent peritoneal  M~ were maintained on 60- 
mm  glass Petri dishes in D10 medium with or without immune or control  LK.  At  54 h,  the 
medium  was  changed  to  methionine-free medium  supplemented  with  60  /ICi/m]  of  [35S]- 
methionine (1017 Ci/mM;  New England Nuclear),  10% dialyzed serum, with or without LK. 
After an additional  14 h,  the monolayers were  washed,  lysed  in  1.2  ml  lysis buffer  (8),  and 
clarified  by  centrifugation  at  45,000 g  for  15  rain  at  4°C.  An  aliquot  (2  ×  106  cpm)  was 
immunoprecipitated for  1 h  at 4°C with a  cocktail that contained  1 pgm each of monoclonal 
antibodies  1.21  J,  B25-1,  and  2.6.  The  immunoprecipitates  were  retrieved  on  protein  A- 
Sepharose coated with immunoselected rabbit anti-rat Ig (N.  L. Cappell Labs, Cochranville, 
Pa.).  Another aliquot  (10 ×  106 cpm)  was  immunoprecipitated  for  1 h  on  B21-2 coupled  to 
cyanogen bromide-activated Sepharose 4B. The Sepharose beads were washed and solubilized 
as previously described  (10),  and the antigens separated  by 4-11%  gradient sodium  dodecyl 
sulfate-polyacrylamide  gel  electrophoresis.  To  quantitate  the  amount  of  labeled  antigen, 
individual bands were excised, solubilized in 20% perchloric acid-20% hydrogen peroxide, and 
counted in the presence of Hydrofluor (National Diagnostics~Inc., Parsippany, N. J.). 
Mixed Leukocyte Reactions (MLR).  B6D2F1 irradiated stimulator Mff or DC (1,500 rad, Cs la7 
source), were added to  16-mm tissue culture wells that contained 4.5 ×  10  e nylon-wool-filtered 
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mouse serum or 1% fetal calf serum.  The cultures were maintained for 3-4 d, the cells were 
harvested,  and  then  [nH]thymidine  uptakes were  measured  in  fresh  medium as  previously 
described  (11). In some cultures, indomethacin (1/~g/ml, Sigma Chemical Co., St. Louis, Mo.) 
was added to block synthesis of inhibitory M¢ prostaglandins  (3, 12). 
Results 
Effect of LK on Ia Antigens of Cultured Mob.  Expression of Ia was followed for 6 d  in 
cultured peritoneal MO.  In one-half of the cultures, the D10  medium was  supple- 
mented with 25% vol:vol immune LK, i.e., culture medium from HKT-boosted T. 
cruzi-immune spleen cells. At each time point, radioiodinated clone B21-2 antibody 
was  used  to  quantitate  (Fig.  1)  and  visualize  (Fig.  2)  M~  Ia.  Throughout  the 
experiments, _>90% of the cells remained attached and were viable in a  trypan blue 
assay. 
At the onset of culture, binding of 125I-anti-Ia  was readily detectable (Fig.  1)  and 
distributed  in  a  heterogeneous fashion  (Fig.  2 A).  A  subpopulation  (5-30%)  of the 
cells were strongly positive. After a day of culture in D10, or D10 with immune LK, 
binding of anti-Ia dropped dramatically (Fig. 1) and <5% of the cells were Ia positive 
by autoradiography (Fig. 2 B). No cell loss was evident during the first day of culture, 
and the levels of other plasma membrane antigens were not decreased (see below). 
Because the initial Ia positive cells were M~ (Materials and Methods), we conclude 
that expression of Ia is short-lived on most peritoneal M~b in culture. 
Ia remained at low levels on Mq~ cultured without LK (Fig.  1, Q--O), and where 
detectable, was always restricted to a  very small subpopulation of cells. But in the 
continued presence of LK, Ia was re-expressed, reaching a plateau level by day 3 (Fig. 
1,  A--A).  At  saturation,  Mq~  expressed  1  ×  105-2  X  105  binding  sites/cell.  By 
radioautography, it was determined that LK induced virtually all cells to express Ia 
(Fig. 2 C). Enhanced expression of Ia was dose-dependent, reaching one-half-maximal 
levels at  1% vol:vol LK and a  plateau at  10% vol:vol (data not shown).  Binding of 
l~I-anti-Ia was specific, because CBA (Ia  k) M~ exposed to LK did not bind the anti 
Ia  b'a reagent above the no cell control (e.g., Fig. 2 D). 
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FiG.  1.  Effects of immune LK on the expression of Ia. Peritoneal Mda were maintained for 6 d  in 
D10 medium (O~)  or immune LK (25%  vol:vol, A--A), all media were changed daily. In one 
additional  set  of cultures,  the  D10  medium was  replaced  by  immune LK  beginning at  day  3 
(A---A), whereas  in  another,  the  LK was  removed by washing and  replaced  by  DI0  at  day  3 
(0---0).  Similar  data  to  those  illustrated  from  day  0-3  were  obtained  in  seven  consecutive 
experiments, whereas day 3-6 data were obtained in 3 consecutive experiments. Fro.  2.  Visualization of ~z~I-821-2  binding sites  (Ia  antigens) on cuhured  peritoneal  Me,.  Both 
phase-contrast  (left)  and bright-field  (right)  micrographs of the radioautograrns are presented to 
visualize all cell profiles and those labeled with lznI-anti-Ia. All micrographs are ×  310. (A)  Initial 
population of adherent cells in which a  subpopulation of cells is Ia positive.  (B)  I d  of culture in 
immune LK. Much of the Ia has disappeared.  (C)  3  d  of culture in immune LK. Ia has been re- 
expressed on most cells. (D) Control for nonspecific binding of lzSI-anti-la. CBA (1-A  k) M~ cultured 
in  immune LK, did  not bind clone  B21-2  (anti-l-Ah'a).  (E)  3  d  of culture in  DI0  medium, la  is 
virtually absent.  (F)  Companion culture to  (E)  in which immune LK was added from 68 to 84 h 
resulting in a  rapid re-expression ofla on most cells. (G)  3 d  of cuhure in control LK. la has been 
re-expressed on a subpopulation of cells. 
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IfMq~ were cultured for 3 d in D10, so that >95% of the cells were Ia negative (Fig. 
2E), addition of LK again resulted in a  re-expression of Ia on most ceils  (Fig.  2F). 
Enhanced binding was detected at 20 h, but not at 6 h  (Fig.  1, A---A). In another set 
of cultures, LK was added for 3 d and then removed by washing. Ia persisted on LK- 
stimulated cells  for at least  2 d  and then fell  (Fig.  1 O--O), in contrast to the short- 
lived nature of Ia on freshly explanted M~. We conclude that immune LK can induce 
most peritoneal M~ to express Ia in a stable form. 
Media from HKT-immune boosted spleen cells  (immune LK) were compared to 
control media from nonimmune spleen cells. Control LK at doses of 5,  10 (Table II), 
and 25% vol:vol (Fig.  3A) induced increases in Ia that were 20-50% that induced by 
immune LK. Somewhat larger increases were seen with media obtained from immune 
spleen  not  boosted with  HKT  (Table  II), but  it  is  likely  that  2-  to  3-wk  72.  cruzi- 1254  LYMPHOKINE  ENHANCES  EXPRESSION OF  MACROPHAGE  [a 
TABLE  II 
Effect of Immune and Control LK On The Expression of Md# Plasma Membrane Antigens 
Nanograms monoclonal antibody bound  Micro- 
Duration of  Source of LK (mouse spleen cul-  grams 
culture  ture medium)  B2 I-2  B25-1  1.21J  2.6  24G2  protein/ 
culture 
Experiment A 
h 
3  None  2.9  .90  6.8  .81  2.2  4.9 
72  T. cmzi immune +  HKT  9.0  2.5  6,9  1,3  3.3  9.1 
72  T. cruzi immune 4- no HKT  5.3  1.9  5.2  1.2  3.6  7.8 
72  7". cruzi nonimmune 4- HKT  3.0  1.4  7.1  1,8  3,5  7.1 
72  T. cruai nonimmune 4- no HKT  2.8  1.2  6.3  1.2  2.7  9.1 
72  None  .09  .76  6.0  1.8  2.0  4.5 
Experiment B 
h 
3  None  3.0  .75  7.4  .61  13  3.0 
72  T. cruai immune +  HKT  4.9  ,87  5.3  2.0  2.7  4,4 
72  T. cruzi immune +  no HKT  3.1  32  5.4  1.5  2.6  4.4 
72  T. cruzi nonimmune +  HKT  1.6  .76  5.6  2.8  2.7  4.0 
72  T. cruz/nonimmune +  no HKT  2.0  .80  6.8  3.6  2.8  4.6 
72  None  .25  .60  4.8  2.5  2.5  4.0 
Two different sets (Experiments A and B) of LK were obtained from 48-h cultures of T. m~zi-immune or 
nonimmune spleen, maintained in the presence or absence of specific antigen HKT. LK was then used to 
supplement the D10 medium of peritoneal M~ cultures.  In Experiment A,  10% vol:vol medium, and in 
Experiment B, 5% vohvol was used. One third more cells were cultured in Experiment A. Binding studies 
were performed with five radioiodinated monoclonal antibodies using concentrations close to the level 
required to saturate all binding sites. An Fab fragment of  clone 24(]-2 was used, whereas the other antibodies 
were DEAE-purified ascites from hybridoma-bearing mice. 
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F1o,  3.  Expression of five plasma membrane antigens on cultured peritoneal M~ at varying times 
in  culture. Cultures were maintained in  DI0 medium (0), or D10  supplemented with immune 
(A---A) or control (×--×) LK. At varying time points, binding studies were performed with l~I- 
monoclonal antibodies. Results  s  are expressed as nanograms bound/cover slip of 1 ×  10  cells. The 
five monoclonals,  described in  Materials and Methods, were B21-2 (anti-I-Ab'd); B25-1  (anti-H- 
2Dd); t.21 J  (Mac-l); 24G2 (anti-Fc);  and 2.6 (another anti-M~). 
infected spleens harbor parasites. Kinetics studies in control LK  showed that Ia first 
decreased and then was re-expressed usually at day 3  (Fig. 3 A). By radioautography, 
it was determined that only a  subpopulation of cells (20-40%)  became Ia positive at 
all  doses (Fig.  2 G).  If addition of control LK  was delayed for 3  d,  the Mq) still  re- 
expressed Ia at  a  level of 30% that induced by immune  LK  (not shown). Treatment STEINMAN, NOGUEIRA, WITMER, TYDINGS, AND MELLMAN  1255 
of immune or nonimmune spleen cells with anti-Thy-1 and complement before the 
culture period when  LK was collected reduced LK activity by 60-90%.  Finally, 2 
samples of medium  from concanavalin A-stimulated, nonimmune spleen cells were 
similar in activity to antigen-induced LK, causing a re-expression of Ia on most if not 
all cultured peritoneal M~ (data not shown). 
Expression of Other Plasma Membrane Antigens In vitro.  To determine if the effects of 
immune and  control LK were restricted to Ia, we performed quantitative binding 
studies  (Fig.  3;  Table  II)  with  four  other  monoclonal  antibodies  (Materials  and 
Methods). Radioautographic data are not presented, because these four monoclonal 
reagents detected antigens that were expressed to a similar extent on all cultured Mq~. 
In contrast to Ia, expression of H-2D MHC determinants remained constant with 
culture at a level of 2 ×  104-3 ×  104 binding sites/cell. By day 2-3, both immune and 
control LK enhanced the level of H-2D, but immune LK usually induced larger and 
more rapid rises.  The levels of 1.21 J  antigen diminished  10-50% during culture in 
D10, but remained close to the starting level of 2.5 ×  105-3.0 ×  105 binding sites/cell 
in both immune or control LK. The trypsin-resistant Fc receptor (clone 24G2;  2 X 
l0  s binding sites/cell)  remained constant  with  culture in  D10 and  increased up to 
twofold with  immune  or  control  LK.  These  increases  closely paralleled  total  cell 
protein/cuhure.  Finally 2.6  antigen  (3  ×  10~-4  ×  10  4  binding sites/cell)  increased 
two- to threefold during culture in D10 or in D10 with LK. In most experiments, the 
level of 2.6 was  lowest in the presence of immune LK. We conclude that  there is a 
wide  range  of behavior  in  the  levels  of  plasma  membrane  antigens  monitored 
simultaneously. The only moieties in which immune LK exerted selective enhancing 
effects were the MHC determinants--Ia and, to a lesser extent, H-2D. 
Biosynthesis of Plasma  Membrane Antigens.  To determine if biosynthesis of Ia  was 
induced by LK, we performed immunoprecipitation studies on cells radiolabeled with 
[~S]methionine,  usually  on  the  third  day  of culture.  Synthesis of Ia  was  readily 
detected in cells treated with immune LK (Fig. 4, lane 2), whereas synthesis of Ia was 
diminished or absent in cells not exposed to LK (Fig. 4, lane 4) or exposed to control 
LK (Fig.  4,  lane 6).  Synthesis of I-E-region alloantigens was also detected in  LK- 
treated cells after immunoprecipitation with a (B I0 X HTI)F1 anti-B 10.A(5R) anti-Ia 
7+ alloantiserum (data not shown). 
To establish  that  radiolabeling  of Ia  antigens  was  selectively increased  in  LK- 
treated cells, we extended the immunoprecipitation analysis with three other mono- 
clonal antibodies. The non-MHC-linked polypeptides (1.21 J, 180,000 and 95,000 mol 
wt and 2.6, 21,000 mol wt) were radiolabeled similarly in the presence or absence of 
LK in  four consecutive experiments. The class  1 MHC  polypeptides  (clone B25-1, 
45,000 and 13,000 mol wt) showed a relative increase in radiolabeling in cells exposed 
to immune LK (Fig. 4; compare lanes  1 with 3 and 5). Because the radiolabeling of 
Ia (clone B21-2) and H-2D (clone B25-1) was increased relative to non-MHC plasma 
membrane antigens  (clones  1.21 J  and 2.6), we conclude that biosynthesis of MHC 
products is enhanced in LK-treated cells. 
Stimulating  Capacity of la-bearing Mep in the  I ° MLR (Table III).  0.2 ×  t05-2 X  105 
LK-induced Ia-bearing M~ were inactive as stimulators of the 1  ° MLR. Because the 
responder cells were harvested and pulsed with [aH]thymidine in fresh medium, we 
verified that proliferating cells were not left behind on the M~ monolayers at the time 
of the  proliferative assays.  In  contrast  to  Ia-bearing  M~b, 0.3  ×  105-1  X  105  DC FIG.  4.  Induction of Ia biosynthesis in M~-treated with immune LK. Peritoneal  Mq~ monolayers 
were labeled with [S6S]methionine at 50-64 h  of culture in 10% vol:vol immune LK (lanes 1 and 2), 
D10 only  (lanes  3  and  4),  and  10%  vol:vol control  LK  (lanes 5  and  6).  Lysates were  subject to 
immunoprecipitation with a cocktail of 1.21 J, B25-1, and 2.6 (lanes I, 3, and 5) or with clone B21- 
2  anti-Ia  (lanes 2,  4,  and  6).  The  labeled  antigens were  separated  on  4-11%  gradient  gels and 
visualized by radioautography. The  polypeptides recognized by each monoclonat antibody have 
been  described  (8,  10)  and  are  indicated  on  the right  side  of the gel, whereas the positions of 
molecular weight standards are on the left. Under conditions in which all cultures actively synthesize 
1.21 J, B25-1, and 2.6 antigens (lanes 1, 3, and 5), immune LK dramatically increases the extent of 
Ia labeling (lane 2 vs. lanes 4 and 6). Synthesis of Ia was weak or undetectahle if M~ were labeled 
after only 1 d  in immune LK. 
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TABLE  III 
Lymphokine-induced la-bearing M~p Do Not Stimulate a 1  ° MLR 
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Stimulating cells 
Proliferative response 
Mouse serum  Fetal calf serum 
cpm [~H]thymidine 
Experiment A 
1.5 ×  106 Mob  535  3,295 
1.5 X  105 +  indomethacin  1,210  2,485 
1.5 ×  106 +  1 ×  104 DC  1,545  4,785 
1.5 ×  l06 +  1 ×  104 +  indomethacin  10,200  12,130 
1 X  105DC  21,165  38,890 
3 ×  104 DC  11,255  15,620 
1 ×  104 DC  7,690  9,210 
1 X 104 +  indomethacin  8,385  11,000 
None  1,960  5,310 
Experiment B 
2 ×  10  b Mga  3,705  1,170 
2 ×  l06 +  indomethacin  1,830  1,910 
2 X  106 +  3 X  104 DC  15,220  16,700 
2 X  105 +  3 X  104 +  indomethacin  22,380  24,660 
1 ×  105 DC  34,870  30,040 
3 ×  104 DC  20,455  27,655 
1 ×  104DC  10,700  10,665 
1 ×  104 +  indomethacin  11,980  10,360 
None  1,875  1,550 
Ia antigens were induced on B6D2F1  peritoneal M~k after 3 d  of culture in immune LK (10% vol:vol). 
These  Mg,  were  then compared  to  Ia-bearing DC  as  1  °  MLR  stimulators  for 4.5  ×  10  s  nylon-wool- 
nunadherent DBA/2 spleen responders. Mqb had  1.5 ×  105 and 2 ×  106 binding sites/cell and DC had 4 
×  106 and 6  ×  l0  b binding sites/cell in experiments A  and B,  as  determined by Scatchard  analysis. 
Proliferative responses were evaluated in cultures supplemented with  1% mouse serum or  l% fetal calf 
serum. In these experiments [3H]thymidine uptakes were performed at day 3 with a 2-h pulse of radiolabel, 
2 #Ci/ml, 6.0 Ci/mM, and are expressed as counts per minute/culture of 4.5 ×  106 cells. Similar findings 
were obtained in two experiments monitored on day 4 of the MLR. 
induced  maximal  responses by day 3-4.  DC  expressed two to four times more  Ia/cell 
as  the  LK-induced  M~k  (data  not  shown).  It  is  difficult  to  ascribe  differences  in 
stimulating capacity to differences in the total level of Ia because  1 ×  104 DC  induced 
a  large MLR  and  2  ×  105 M0  did not. 
Addition  of indomethacin  to block the possible release of inhibitory prostaglandins 
did not increase M0  stimulatory capacity. Mob could inhibit the DC-stimulated  MLR, 
however  (Table  III,  experiment  A).  This  inhibition  was  reversed  by  addition  of 
indomethacin.  Similar phenomena  were observed previously in studies of the inhibi- 
tory effects of Mg} on DC-mediated  accessory function (3). We conclude that expression 
of Ia on Mqb is not in itself sufficient to sensitize alloreactive T  cells at  the stimulator 
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Discussion 
This study represents a  fusion of two kinds of investigation. In one, we study Ia 
antigens  on  subpopulations  of mouse cells  (M~,  B  cells,  and  DC)  to  try to  relate 
expression of Ia to immunologic functions such as accessory cell activity and stimu- 
lation of the  1  °  MLR  (3,  11). In the other, we investigate mechanisms and specific 
changes consequent to the activation of M~ by immune cells and their products (4- 
6). We report that LK from antigen-stimulated T. cruzi-immune spleen cells enhances 
the expression and synthesis of Mq, Ia in a dose- and time-dependent fashion. Increase 
in  Ia joins  a  long  list  of Mq~  properties  induced  by  this  source of LK including: 
spreading, secretion of plasminogen activator, capacity to release hydrogen peroxide, 
and ability to kill  T.  cruzi  and tumor cells (4-6). These changes probably occur on 
most cells in the peritoneal Mq, population.  Enhanced levels of Ia, like secretion of 
plasminogen  activator  (4),  is  particularly  sensitive  to  the  addition  of LK.  As  a 
consequence, it is not surprising that control LK from nonirnmune spleen can exert 
similar but quantitatively less impressive changes. Nonimmune spleen may have cells 
sensitized to environmental antigens and may release the same mediators as immune- 
boosted cells.  Alternatively, distinct factors may be present in control LK. We noted 
that the latter induced the expression of Ia only a subpopulation of cells, at all doses, 
in contrast to immune LK, which enhanced Ia on most, if not all cells (compare Fig. 
2 C, F, and G). 
In effect, expression of Ia on cultured peritoneal cells represents a  surface marker 
that correlates with LK-induced M~ activation (4-6). The level of Ia may be a simple, 
quantitative, and rapid assay (Fig. 1 A---A; Fig. 2 E and F) for monitoring experiments 
characterizing the cells and mediators involved in the activation process. M~ obtained 
from the peritoneal cavities of immune-boosted mice also exhibit most parameters of 
Mq~ activation (13) and are strongly Ia positive (3,  14). However in situ, these changes 
may be mediated by LK and  other factors that  act both in the tissues  (peritoneal 
cavity) or during Mq~ development (marrow and peripheral blood). 
The availability of monoclonal antibodies was critical for the execution of these 
experiments.  Binding  data  with  a  battery  of monoclonal  reagents  indicated  that 
expression of Ia, and to a  lesser extent H-2D, was selectively enhanced by immune 
LK. The expression of three other plasma  membrane antigens,  detected by clones 
1.21 J, 2.6, and 24G2, was not appreciably altered by immune relative to control LK 
(Fig.  3  and Table II).  Similar quantitative data would  be difficult to obtain  from 
small numbers of adherent cells using cytotoxicity, indirect immunofluorescence, or 
absorption assays. In biosynthesis studies (Fig. 4), radiolabeling of Ia was selectively 
increased by immune LK, whereas radiolabeling of non-MHC polypeptides recog- 
nized by clones 1.21 J  and 2.6 was similar in all cultures. Using the latter polypeptides 
as controls, we concluded that radiolabeling of Ia reflects an induction of Ia biosyn- 
thesis. Finally, the rat anti-mouse monoclonal antibody clone B2 I-2 is specific for the 
Ia  b'd haplotype (Table I).  Binding above the no-cell background was  only seen on 
Ia  b'd cells treated with LK [e.g.,  C57BL/6, DBA/2, C6D2F1, B10A(5R)] and not Ia  k 
M~ (CBA; Fig. 2 C and D). By using LK from T. cruzi-immune CBA spleen cells, we 
ensured that the increase in Ia we observed was derived from the treated Mq~ and not 
adsorbed from the applied LK. 
It is not clear if all members of the mononuclear phagocyte lineage increase Ia in 
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population  reproducibly  (15  consecutive experiments)  increased  Ia  in  the  manner 
reported here. Less dramatic increases in Ia were usually found in LK-treated, resident 
peritoneal, and spleen M~. Tissue culture itself also seemed to enhance susceptibility 
to LK. It took 24-48 h  for LK to induce large increases in Ia on freshly explanted 
Mff, whereas cells that had been cultured 2-3 d exhibited one-half-maximal responses 
by  20  h  (Fig.  1).  Possibly,  fetal  calf serum  and/or  endotoxin  contribute  to  the 
enhanced responsiveness of cultured Mth (15). 
Several factors may contribute to enhanced  levels of Ia.  A  primary mechanism 
seems  to be the  induction  of biosynthesis  in  Mq~ exposed to  LK.  (Fig.  4).  Other 
alterations that  might occur in the presence of LK include:  decreased degradation 
rates of pre-existing Ia;  mobilization of Ia from pre-formed intracellular pools; and 
increased accessibility of surface Ia to the 12SI-anti-Ia probe. 
Ia on freshly explanted peritoneal M~b exhibits several differences from Ia induced 
by immune LK. Endogenous Ia is heterogeneous in its distribution and short-lived in 
vitro, whereas LK-induced Ia is found on most cells and is more long-lived. The rapid 
and selective loss of Ia from the surface of peritoneal Mtk is a puzzling finding. Other 
plasma membrane constituents turnover much more slowly with a tl/2 of >24 h  (16). 
Ia on explanted peritoneal cells may be analogous to myeloperoxidase; that  is,  it is 
actively synthesized by immature mononuclear phagocytes, persists for a finite period 
after cessation of synthesis, and then diminishes rapidly. 
Previous  studies  on  cultured  rodent  M~  have  emphasized  that  Ia  is  a  stable 
phenotype for a  Mq~ subpopulation.  However, most Mth Ia disappears rapidly from 
the cell surface during culture. LK then induces Ia on virtually all cells. These findings 
indicate  that  Ia  on  tissues  Mth  is  not  a  constitutive  trait.  Like  many  other  Mth 
properties, Ia may be altered by environmental factors, including tissue culture and 
immunologic stimuli. 
How then would increased expression of Mth Ia contribute to the cellular immune 
response and to the biologic effects of LK? One hypothesis is that Ia is able to form 
some sort of  complex with antigen (antigen processing or presentation) that is required 
for T cell stimulation. We did not test this possibility directly, but we did examine the 
ability of Ia-bearing Mth to stimulate a  proliferative response in allogeneic T  ceils. 
The M~ were inactive, even when indomethacin was added to diminish the synthesis 
of inhibitory prostaglandins  (Table III). Conceivably, LK-induced Mq~ inhibit their 
own  functional capacities  in  vitro by an  indomethacin-insensitive  process.  This  is 
unlikely, because DC were fully capable of triggering the MLR in the presence of 
these Mff. Our  data  thus extend previous observations on the  different functional 
properties of Ia-bearing DC and Ia-positive Mth generated in situ  (3,  10).  Ia on the 
surface  of Mq~  may  be  intrinsically  different  from  Ia  on  the  surface  of DC,  or 
additional non-MHC factors are utilized by DC in functional assays. 
We favor the idea that increased expression of Ia, and possibly H-2K/D, enhances 
the ability of T  cells to interact directly with M4,. The T  cells that secrete LK and 
that activate M~ are likely to be selected to recognize self-MHC determinants. Direct 
T-Mq~ interaction would enable the T  cells and/or LK products to more efficiently 
activate Mtb function. The initial generation of MHC-restricted effector ceils however 
may be mediated by Ia-bearing DC  (3).  A  similar requirement for MHC  products 
mediating T-B interaction during B cell activation has been proposed (17). 1260  LYMPHOKINE ENHANCES EXPRESSION OF  MACROPHAGE Ia 
Summary 
Soluble  products  from antigen  stimulated  T~ypanosoma cruzi-immune  spleen  cells 
enhanced the expression of Ia antigens on proteose-peptone-elicited mouse peritoneal 
macrophages (M~b). Acquisition of Ia paralleled Mq~ activtion, previously shown to be 
mediated by this same source of lymphokine (LK). 
Expression  of Ia  and  four  other  plasma  membrane  antigens  was  monitored  by 
quantitative  binding and radioautographic studies with  l~SI-monoclonal antibodies. 
Immune  LK  selectively  enhanced  expression  of Ia  and,  to  a  lesser  extent,  H-2D 
relative to control LK from antigen-stimulated noninfected spleen. The levels of three 
other non-major histocompatibility complex (MHC) antignes, including the trypsin- 
resistant Fc receptor, were similar in cells exposed to both sources of LK. As little as 
1% immune LK induced one-half maximal expression of Ia. Kinetic studies revealed 
that much of the Ia on freshly explanted peritoneal Mg} was lost during the  1st d of 
culture. In the continued presence of immune LK, Ia was re-expressed on virtually all 
M~ by the 2nd and 3rd d. Alternatively, >95% Ia negative populations were obtained 
by culturing the cells 3 d; then, addition of LK induced  Ia on most cells within  1 d. 
Once induced, Ia persisted on the M4} surface for at least 2 d. 
[35S]methionine  radiolabeling  indicated  that  immune  LK  selectively  increased 
radiolabeling of M~ Ia, again with other non-MHC-linked plasma membrane poly- 
peptides as controls. 
LK-induced  Ia-bearing  M~  were  tested  as  primary  mixed  leukocyte  reaction 
stimulators.  1 ×  10°-2  ×  10  s  Mth  did  not  stimulate  4.5  ×  10  6  responding  T  cells, 
whereas  10  4 dendritic cells induced strong responses, as previously described. Because 
Ia-positive Mth  do  not  actively sensitize  T  cells  in  a  model  immune  response,  we 
propose that  Mth  MHC  products serve primarily as recognition  sites for previously 
sensitized T  cells, thereby enhancing T  cell-mediated Mth activation. 
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